GC4419 for Pancreatic Cancer
What is the Purpose of this Study?
Who Can Participate in this Study?
-Have pancreatic cancer that cannot be surgically removed
What is Involved?
If you choose to join the study, you will:
-Be randomized (like flipping a coin) into one of two groups:
--Group A will get the study drug (GC4419) and Group B will get a placebo (harmless medicine)
-Have a physical exam
-Have a CT scan
-Have an endoscopy
-Have a blood draw
RADIATION THERAPY IN COMBINATION WITH RADIOMODULATING AGENT GC4419 IN LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA